While further studies are necessary to establish the role of SAA in platelet adhesion, our results suggest that inhibition of SAA binding to platelets or reduction of serum SAA levels might decrease COVID-19-associated thrombotic complications. This evidence concerns the gene SAA2 and COVID-19.